RNTX
Vanguard Group’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.24M | Buy |
884,107
+167,319
| +23% | +$234K | ﹤0.01% | 3684 |
|
2025
Q1 | $1.27M | Buy |
716,788
+291,794
| +69% | +$516K | ﹤0.01% | 3639 |
|
2024
Q4 | $977K | Sell |
424,994
-7,207
| -2% | -$16.6K | ﹤0.01% | 3772 |
|
2024
Q3 | $1.53M | Sell |
432,201
-73,952
| -15% | -$262K | ﹤0.01% | 3640 |
|
2024
Q2 | $1.4M | Buy |
506,153
+465,839
| +1,156% | +$1.29M | ﹤0.01% | 3679 |
|
2024
Q1 | $267K | Hold |
40,314
| – | – | ﹤0.01% | 4128 |
|
2023
Q4 | $123K | Buy |
40,314
+380
| +1% | +$1.16K | ﹤0.01% | 4277 |
|
2023
Q3 | $60.7K | Sell |
39,934
-539
| -1% | -$819 | ﹤0.01% | 4388 |
|
2023
Q2 | $72.4K | Sell |
40,473
-18,626
| -32% | -$33.3K | ﹤0.01% | 4417 |
|
2023
Q1 | $73.3K | Sell |
59,099
-71,216
| -55% | -$88.3K | ﹤0.01% | 4428 |
|
2022
Q4 | $309K | Sell |
130,315
-2,474,792
| -95% | -$5.87M | ﹤0.01% | 4215 |
|
2022
Q3 | $539K | Sell |
2,605,107
-488,121
| -16% | -$101K | ﹤0.01% | 4192 |
|
2022
Q2 | $804K | Hold |
3,093,228
| – | – | ﹤0.01% | 4155 |
|
2022
Q1 | $1.59M | Sell |
3,093,228
-332,884
| -10% | -$171K | ﹤0.01% | 4053 |
|
2021
Q4 | $1.93M | Sell |
3,426,112
-18,859
| -0.5% | -$10.6K | ﹤0.01% | 4051 |
|
2021
Q3 | $3.51M | Buy |
3,444,971
+4,338
| +0.1% | +$4.43K | ﹤0.01% | 3844 |
|
2021
Q2 | $4.3M | Sell |
3,440,633
-215,315
| -6% | -$269K | ﹤0.01% | 3672 |
|
2021
Q1 | $5.23M | Buy |
3,655,948
+3,211,730
| +723% | +$4.59M | ﹤0.01% | 3509 |
|
2020
Q4 | $462K | Buy |
444,218
+197,917
| +80% | +$206K | ﹤0.01% | 3968 |
|
2020
Q3 | $318K | Buy |
246,301
+21,983
| +10% | +$28.4K | ﹤0.01% | 3893 |
|
2020
Q2 | $265K | Hold |
224,318
| – | – | ﹤0.01% | 3887 |
|
2020
Q1 | $74K | Sell |
224,318
-8,072
| -3% | -$2.66K | ﹤0.01% | 3974 |
|
2019
Q4 | $133K | Hold |
232,390
| – | – | ﹤0.01% | 3983 |
|
2019
Q3 | $156K | Sell |
232,390
-100,615
| -30% | -$67.5K | ﹤0.01% | 3987 |
|
2019
Q2 | $240K | Buy |
333,005
+240,910
| +262% | +$174K | ﹤0.01% | 3947 |
|
2019
Q1 | $180K | Buy |
92,095
+5,378
| +6% | +$10.5K | ﹤0.01% | 3943 |
|
2018
Q4 | $73K | Sell |
86,717
-9,698
| -10% | -$8.16K | ﹤0.01% | 4035 |
|
2018
Q3 | $265K | Buy |
96,415
+7,109
| +8% | +$19.5K | ﹤0.01% | 3965 |
|
2018
Q2 | $484K | Sell |
89,306
-2,388
| -3% | -$12.9K | ﹤0.01% | 3827 |
|
2018
Q1 | $745K | Buy |
91,694
+12,819
| +16% | +$104K | ﹤0.01% | 3716 |
|
2017
Q4 | $831K | Buy |
78,875
+21,540
| +38% | +$227K | ﹤0.01% | 3651 |
|
2017
Q3 | $767K | Buy |
57,335
+47,335
| +473% | +$633K | ﹤0.01% | 3660 |
|
2017
Q2 | $111K | Buy |
+10,000
| New | +$111K | ﹤0.01% | 3981 |
|